| Dr Hildy Brown, MSPT, DPT | |
|
46520 County Road 48, Southold, NY 11971-5040 | |
| (631) 765-9389 | |
| Not Available |
| Full Name | Dr Hildy Brown |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 46520 County Road 48, Southold, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487859484 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 017896-1 (New York) | Primary |
| Provider Name | Sports Physical Therapy Occupational Therapy And Rehabilitation Servic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770540593 PECOS PAC ID: 0446140446 Enrollment ID: O20040315001603 |
News Archive
Keeping the lungs healthy could be an important way to retain thinking functions that relate to problem-solving and processing speed in one's later years, new research suggests.
A study of more than 1.3 million Australians with diabetes has found that kidney failure is increasing in people with type 2 diabetes aged under 50 years, leading to reduced quality of life and placing growing demand on the country's kidney dialysis and transplantation services.
Cornerstone Pharmaceuticals, Inc. has announced the publication of data from preclinical studies on EmPAC™, its nanoparticle reformulation of paclitaxel, in the August issue of the Journal of Nanoscience and Nanotechnology. The publication highlights data demonstrating improved safety and efficacy of EmPAC™ versus Taxol®, the generic formulation of paclitaxel and one of the most widely prescribed chemotherapies. EmPAC™ is a nanoemulsion formulation of Paclitaxel and is the lead product candidate of Cornerstone's proprietary Emulsiphan™ cancer selective delivery nanotechnology platform. Taxol®, an injectable formulation of Paclitaxel, is currently used to treat a variety of cancers, including ovarian carcinomas, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma.
An unprecedented level of federal funding for pain research, some $400 million, was allocated in 2010 by the National Institutes of Health (NIH) through provisions of the American Recovery and Investment Act and the Affordable Care Act to help accelerate advances in pain research, prevention and treatment.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hildy Brown, MSPT, DPT 46 Evelyn Ct, Manorville, NY 11949-2810 Ph: (631) 943-8774 | Dr Hildy Brown, MSPT, DPT 46520 County Road 48, Southold, NY 11971-5040 Ph: (631) 765-9389 |
News Archive
Keeping the lungs healthy could be an important way to retain thinking functions that relate to problem-solving and processing speed in one's later years, new research suggests.
A study of more than 1.3 million Australians with diabetes has found that kidney failure is increasing in people with type 2 diabetes aged under 50 years, leading to reduced quality of life and placing growing demand on the country's kidney dialysis and transplantation services.
Cornerstone Pharmaceuticals, Inc. has announced the publication of data from preclinical studies on EmPAC™, its nanoparticle reformulation of paclitaxel, in the August issue of the Journal of Nanoscience and Nanotechnology. The publication highlights data demonstrating improved safety and efficacy of EmPAC™ versus Taxol®, the generic formulation of paclitaxel and one of the most widely prescribed chemotherapies. EmPAC™ is a nanoemulsion formulation of Paclitaxel and is the lead product candidate of Cornerstone's proprietary Emulsiphan™ cancer selective delivery nanotechnology platform. Taxol®, an injectable formulation of Paclitaxel, is currently used to treat a variety of cancers, including ovarian carcinomas, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma.
An unprecedented level of federal funding for pain research, some $400 million, was allocated in 2010 by the National Institutes of Health (NIH) through provisions of the American Recovery and Investment Act and the Affordable Care Act to help accelerate advances in pain research, prevention and treatment.
› Verified 1 days ago
Madison Gore, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 46520 County Road 48, Southold, NY 11971 Phone: 631-765-9389 | |
Ms. Lynn A Cataldo, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 57190 Main Rd, Southold, NY 11971 Phone: 631-765-3620 Fax: 631-765-0013 | |
Gary A. Despres Physical Therapy P.c. Physical Therapist Medicare: Medicare Enrolled Practice Location: 53345 Main Road, Building 8 Unit 1, Southold, NY 11971 Phone: 631-806-2179 | |
Karen Christine Mitchell, P.T. Physical Therapist Medicare: Medicare Enrolled Practice Location: 775 Hummel Ave, Southold, NY 11971 Phone: 631-765-8417 | |
Noreen Bawn Kelly, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 375 Kenneys Rd, Southold, NY 11971 Phone: 631-245-2813 | |
Mary E Whyard, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 690 Oriole Dr, Southold, NY 11971 Phone: 516-658-7215 | |
Mr. Daniel R Charlebois, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 46520 North Rd, Southold, NY 11971 Phone: 631-765-9389 Fax: 631-765-9369 |